Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder

BACKGROUND AND OBJECTIVE: Daridorexant is a dual orexin receptor antagonist for the treatment of insomnia. In two phase III, 12-week studies in patients with insomnia disorder, daridorexant improved sleep and daytime functioning while maintaining a favorable safety profile. The objective of this 40-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunz, Dieter, Dauvilliers, Yves, Benes, Heike, García-Borreguero, Diego, Plazzi, Giuseppe, Seboek Kinter, Dalma, Coloma, Preciosa, Rausch, Magdalene, Sassi-Sayadi, Mouna, Thein, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829592/
https://www.ncbi.nlm.nih.gov/pubmed/36484969
http://dx.doi.org/10.1007/s40263-022-00980-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829592/
https://www.ncbi.nlm.nih.gov/pubmed/36484969
http://dx.doi.org/10.1007/s40263-022-00980-8

Ejemplares similares